SCHEMBL29351998

SCHEMBL29351998

COc1ccc(-c2ccccc2)c(CCOc2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.47
DRD4 P21917 1/20 0.47
DRD3 P35462 1/20 0.47
MAPT P10636 6/20 0.45
LMNA P02545 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPK1 P28482 2/20 0.45
XBP1 P17861 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP11B1 P15538 3/20 0.45
CYP11B2 P19099 3/20 0.45
CYP19A1 P11511 2/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 4/20 0.44
NPSR1 Q6W5P4 1/20 0.44
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529944 1.00 DRD2 (0.47) DRD2DRD4DRD3MAPTLMNA
SCHEMBL22529979 0.86 MAPT (0.53) DRD2DRD4DRD3MAPTLMNA
SCHEMBL29349920 0.85 DRD2 (0.53) DRD2DRD4DRD3MAPTLMNA
SCHEMBL4611909 0.85 DRD2 (0.53) DRD2DRD4DRD3MAPTLMNA
SCHEMBL22530087 0.82 HSPB1 (0.51) DRD2DRD4DRD3MAPTLMNA
SCHEMBL29353486 0.82 HSPB1 (0.51) DRD2DRD4DRD3MAPTLMNA
SCHEMBL22548861 0.81 RAB9A (0.51) MAPTSMN1; SMN2MAPK1TDP1CYP11B1
SCHEMBL29351951 0.80 ALDH1A1 (0.47) MAPTLMNASMN1; SMN2KMT2AMEN1
SCHEMBL22529956 0.80 ALDH1A1 (0.47) MAPTLMNASMN1; SMN2KMT2AMEN1
SCHEMBL10138011 0.78 APP (0.51) MAPTLMNASMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994001-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-11-22 CN disclosed
CN-113966324-B NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-09-03 CN disclosed
EP-3953335-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS Cellestia Biotech AG (CH) 2022-02-16 EP disclosed
CN-113966324-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2022-01-21 CN disclosed